Ocean Bio-Chem, Inc.

NasdaqCM:OBCI Stock Report

Market Cap: US$123.9m

This company has been acquired

The company may no longer be operating, as it has been acquired. Find out why through their latest events.

Ocean Bio-Chem Management

Management criteria checks 4/4

Key information

Peter Dornau

Chief executive officer

US$356.6k

Total compensation

CEO salary percentage62.4%
CEO tenure49.6yrs
CEO ownership2.8%
Management average tenure16.9yrs
Board average tenure15yrs

Recent management updates

This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Jan 01
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

Dec 15
Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Nov 21
A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Recent updates

Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly

Jun 23
Here's Why Ocean Bio-Chem (NASDAQ:OBCI) Can Manage Its Debt Responsibly

Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future

Apr 07
Capital Investments At Ocean Bio-Chem (NASDAQ:OBCI) Point To A Promising Future

Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine

Dec 16
Ocean Bio-Chem (NASDAQ:OBCI) Might Become A Compounding Machine

Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03

Nov 26
Ocean Bio-Chem's (NASDAQ:OBCI) Dividend Will Be US$0.03

Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings

Nov 22
Ocean Bio-Chem's (NASDAQ:OBCI) Shareholders Have More To Worry About Than Only Soft Earnings

These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely

Nov 03
These 4 Measures Indicate That Ocean Bio-Chem (NASDAQ:OBCI) Is Using Debt Safely

Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03

Sep 02
Ocean Bio-Chem (NASDAQ:OBCI) Will Pay A Dividend Of US$0.03

With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting

Aug 17
With EPS Growth And More, Ocean Bio-Chem (NASDAQ:OBCI) Is Interesting

Ocean Bio-Chem And Its Real Value

Aug 05

Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?

Jul 27
Is Ocean Bio-Chem (NASDAQ:OBCI) A Risky Investment?

Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

May 29
Estimating The Intrinsic Value Of Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital

May 17
Investors Should Be Encouraged By Ocean Bio-Chem's (NASDAQ:OBCI) Returns On Capital

Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly

Mar 17
Ocean Bio-Chem (NASDAQ:OBCI) Seems To Use Debt Rather Sparingly

Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend

Mar 05
Be Sure To Check Out Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Before It Goes Ex-Dividend

Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar

Feb 22
Why Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Is A Dividend Rockstar

Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)

Feb 09
Why We Like The Returns At Ocean Bio-Chem (NASDAQ:OBCI)

Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Jan 27
Is Weakness In Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Stock A Sign That The Market Could be Wrong Given Its Strong Financial Prospects?

Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?

Jan 14
Do Ocean Bio-Chem's (NASDAQ:OBCI) Earnings Warrant Your Attention?

This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Jan 01
This Insider Has Just Sold Shares In Ocean Bio-Chem, Inc. (NASDAQ:OBCI)

Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return

Dec 28
Shareholders of Ocean Bio-Chem (NASDAQ:OBCI) Must Be Delighted With Their 610% Total Return

Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

Dec 15
Ocean Bio-Chem, Inc. (NASDAQ:OBCI) Insiders Have Been Selling

Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?

Dec 03
Is Ocean Bio-Chem (NASDAQ:OBCI) Using Too Much Debt?

Ocean Bio-Chem goes ex-dividend tomorrow

Dec 01

Ocean Bio-Chem authorizes $3M share repurchase program

Nov 23

A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Nov 21
A Quick Analysis On Ocean Bio-Chem's (NASDAQ:OBCI) CEO Salary

Ocean Bio-Chem Has Maintained Momentum, But Not Enough For New Highs

Nov 19

CEO Compensation Analysis

How has Peter Dornau's remuneration changed compared to Ocean Bio-Chem's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2022n/an/a

US$5m

Mar 31 2022n/an/a

US$8m

Dec 31 2021US$357kUS$222k

US$8m

Sep 30 2021n/an/a

US$9m

Jun 30 2021n/an/a

US$10m

Mar 31 2021n/an/a

US$11m

Dec 31 2020US$319kUS$208k

US$10m

Sep 30 2020n/an/a

US$9m

Jun 30 2020n/an/a

US$6m

Mar 31 2020n/an/a

US$3m

Dec 31 2019US$294kUS$200k

US$3m

Sep 30 2019n/an/a

US$3m

Jun 30 2019n/an/a

US$3m

Mar 31 2019n/an/a

US$3m

Dec 31 2018US$312kUS$195k

US$3m

Sep 30 2018n/an/a

US$3m

Jun 30 2018n/an/a

US$3m

Mar 31 2018n/an/a

US$3m

Dec 31 2017US$300kUS$183k

US$3m

Sep 30 2017n/an/a

US$3m

Jun 30 2017n/an/a

US$3m

Mar 31 2017n/an/a

US$3m

Dec 31 2016US$260kUS$171k

US$2m

Sep 30 2016n/an/a

US$2m

Jun 30 2016n/an/a

US$479k

Mar 31 2016n/an/a

-US$64k

Dec 31 2015US$210kUS$161k

US$461k

Compensation vs Market: Peter's total compensation ($USD356.57K) is below average for companies of similar size in the US market ($USD770.24K).

Compensation vs Earnings: Peter's compensation has been consistent with company performance over the past year.


CEO

Peter Dornau (82 yo)

49.6yrs

Tenure

US$356,571

Compensation

Mr. Peter G. Dornau co-founded Ocean Bio-Chem Inc. and has been its Chief Executive Officer, President, Chairman and Director since 1973.


Leadership Team

NamePositionTenureCompensationOwnership
Peter Dornau
Co-Founder49.6yrsUS$356.57k2.79%
$ 3.5m
Jeffrey Barocas
CFO, VP of Finance & Director15.4yrsUS$302.48k1.89%
$ 2.3m
William Dudman
COO, VP18.3yrsUS$305.11k2.7%
$ 3.3m
Gregor Dornau
Executive VP of Sales & Marketing and Director15yrsUS$388.43k4.8%
$ 6.0m
Anca Vague
Controller of Financial Reportingno datano datano data

16.9yrs

Average Tenure

65.5yo

Average Age

Experienced Management: OBCI's management team is seasoned and experienced (16.9 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Peter Dornau
Co-Founder49.6yrsUS$356.57k2.79%
$ 3.5m
Jeffrey Barocas
CFO, VP of Finance & Director15yrsUS$302.48k1.89%
$ 2.3m
William Dudman
COO, VP15yrsUS$305.11k2.7%
$ 3.3m
Gregor Dornau
Executive VP of Sales & Marketing and Director15yrsUS$388.43k4.8%
$ 6.0m
James Kolisch
Director24.3yrsUS$14.95k0.76%
$ 941.6k
John Turner
Independent Director22.2yrsUS$17.75k0.84%
$ 1.0m
Diana Conard
Independent Director11.3yrsUS$17.75k0.063%
$ 77.8k
Kimberly Krause
Independent Director6.1yrsUS$17.75k0.053%
$ 65.2k

15.0yrs

Average Tenure

64yo

Average Age

Experienced Board: OBCI's board of directors are seasoned and experienced ( 15 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.